Patents by Inventor Geoffrey C. Schild

Geoffrey C. Schild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Influenza vaccine
    Patent number: 5162112
    Abstract: A strain of influenza virus, especially human influenza type A or B, for use in formulating a vaccine is selected by a process which comprises isolating candidate influenza viruses in embryonated hens' eggs, determining whether they have antigenic similarities to strains which are the same except that they have been isolated and grown exclusively in animal cells, that is to say whether they are "cell-like", and selecting at least one such cell-like strain or a reassortant thereof having its HA and NA genes for the vaccine.
    Type: Grant
    Filed: April 9, 1990
    Date of Patent: November 10, 1992
    Assignee: National Research Development Corporation
    Inventors: John S. Oxford, James S. Robertson, Geoffrey C. Schild, David A. Tyrrell
  • Peptides useful in vaccination against enteroviruses
    Patent number: 4857634
    Abstract: A synthetic peptide, suitable for use in vaccination against or diagnosis of a disease caused by an enterovirus and especially by a poliovirus, is the peptide coded for by codons 286-290 in the RNA sequence coding for the structural capsid protein VP1 of poliovirus type 3 Sabin strain or by equivalent codons of another enterovirus or is an antigenic equivalent thereof, the numbers of the codons being counted from the 5'-terminus of the nucleotide sequence coding for the VP1 capsid protein.
    Type: Grant
    Filed: August 24, 1987
    Date of Patent: August 15, 1989
    Assignee: National Research Development Corporation
    Inventors: Philip D. Minor, David M. A. Evans, Geoffrey C. Schild, Jeffrey W. Almond, Morag Ferguson
  • Polypeptides useful in vaccination against enteroviruses
    Patent number: 4810491
    Abstract: A synthetic polypeptide, suitable for use in vaccination against or diagnosis of a disease caused by an enterovirus, is an octapeptide coded for by codons 93-100 in the RNA sequence coded for the structural capsid protein VP1 for poliovirus type 3 Sabin strain or by equivalent codons of another enterovirus or is an antigenic equivalent of such an octapeptide, the numbers of the codons being counted from the 5'-terminus of the nucleotide sequence for the VP1 capsid protein.
    Type: Grant
    Filed: July 2, 1987
    Date of Patent: March 7, 1989
    Assignee: National Research Development Corporation
    Inventors: Philip D. Minor, David M. A. Evans, Geoffrey C. Schild, Jeffrey W. Almond
  • Polypeptides useful in vaccination against enteroviruses
    Patent number: 4694071
    Abstract: A synthetic polypeptide, suitable for use in vaccination against or diagnosis of a disease caused by an enterovirus, is an octapeptide coded for by codons 93-100 in the RNA sequence coded for the structural capsid protein VP1 for poliovirus type 3 Sabin strain or by equivalent codons of another enterovirus or is an antigenic equivalent of such an octapeptide, the numbers of the codons being counted from the 5'-terminus of the nucleotide sequence for the VP1 capsid protein.
    Type: Grant
    Filed: June 8, 1984
    Date of Patent: September 15, 1987
    Assignee: National Research Development Corporation
    Inventors: Jeffrey W. Almond, Phillip D. Minor, David M. A. Evans, Geoffrey C. Schild